CompoAtlas

Triphala

Food supplement declared in France, decision dated 20 August 2026

Triphala (Nidelya) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Nidelya
Food business operator placing the product on the market
NIDELYA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Pilule
Daily dose
2 gélules, soit 1000 MG
Directions for use
Prendre 2 gélules par jour, avec un grand verre d'eau, de préférence le soir.
Intended populations
Hommes et femmes de 18 ans et plus
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Transit, Digestion, Antioxydant
Flavourings
Naturel

Declaration 373508, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Terminalia bellerica (Gaertn.) Roxb.FruitExtrait sec aqueux333.4 mg
Terminalia chebula Retz.FruitExtrait sec aqueux333.4 mg
Phyllanthus emblica L.FruitExtrait sec aqueux333.4 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Nidelya

Enter to analyse, Shift+Enter for a new line